Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Pain Patch Market, by Distribution Channel
1.4.2 North America Pain Patch Market, by Type
1.4.3 North America Pain Patch Market, by Product Type
1.4.4 North America Pain Patch Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Pain Patch Market by Distribution Channel
3.1 North America Drug Stores & Retail Pharmacies Market by Country
3.2 North America Hospital Pharmacies Market by Country
3.3 North America Online Providers Market by Country
Chapter 4. North America Pain Patch Market by Type
4.1 North America Prescription Medicines Market by Country
4.2 North America OTC Medicines Market by Country
Chapter 5. North America Pain Patch Market by Product Type
5.1 North America Non-Opioid Patches Market by Country
5.2 North America Pain Patch Market by Non-Opioid Patches Type
5.2.1 North America Nonsteroidal Anti-Inflammatory Drugs Market by Country
5.2.2 North America Methyl Salicylate Market by Country
5.2.3 North America Lidocaine Market by Country
5.2.4 North America Others Market by Country
5.3 North America Opioid Patches Market by Country
Chapter 6. North America Pain Patch Market by Country
6.1 US Pain Patch Market
6.1.1 US Pain Patch Market by Distribution Channel
6.1.2 US Pain Patch Market by Type
6.1.3 US Pain Patch Market by Product Type
6.1.3.1 US Pain Patch Market by Non-Opioid Patches Type
6.2 Canada Pain Patch Market
6.2.1 Canada Pain Patch Market by Distribution Channel
6.2.2 Canada Pain Patch Market by Type
6.2.3 Canada Pain Patch Market by Product Type
6.2.3.1 Canada Pain Patch Market by Non-Opioid Patches Type
6.3 Mexico Pain Patch Market
6.3.1 Mexico Pain Patch Market by Distribution Channel
6.3.2 Mexico Pain Patch Market by Type
6.3.3 Mexico Pain Patch Market by Product Type
6.3.3.1 Mexico Pain Patch Market by Non-Opioid Patches Type
6.4 Rest of North America Pain Patch Market
6.4.1 Rest of North America Pain Patch Market by Distribution Channel
6.4.2 Rest of North America Pain Patch Market by Type
6.4.3 Rest of North America Pain Patch Market by Product Type
6.4.3.1 Rest of North America Pain Patch Market by Non-Opioid Patches Type
Chapter 7. Company Profiles
7.1 NEXGEL, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Research & Development Expenses
7.2 Viatris, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Research & Development Expense
7.3 Johnson & Johnson
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental &Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 SWOT Analysis
7.4 Teva Pharmaceutical Industries Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expenses
7.4.5 Recent strategies and developments:
7.4.5.1 Product Launches and Product Expansions:
7.5 Grünenthal GmbH
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Approvals & Trials:
7.6 Sorrento Therapeutics, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.6.4 Research & Development Expenses
7.7 Hisamitsu Pharmaceutical Co. Inc.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Recent strategies and developments:
7.7.3.1 Product Launches and Product Expansions:
7.8 Endo International PLC
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
7.8.4 Research & Development Expense
7.9 Purdue Pharma L.P.
7.9.1 Company Overview
7.10. Amneal Pharmaceuticals, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental Analysis
7.10.4 Research & Development Expenses
7.10.5 Recent strategies and developments:
7.10.5.1 Partnerships, Collaborations, and Agreements:
7.10.5.1 Approvals & Trials:
Unique Offerings 
